Zenolution, General Public Subscription Competition Rate 894.67 to 1... "Listing on KOSDAQ on the 24th"

[Asia Economy Reporter Hyunseok Yoo] The public offering subscription for Genolution, which is preparing for a transfer listing to the KOSDAQ market, recorded a competition rate of 894.67 to 1.

According to the lead underwriter Shin Young Securities on the 16th, 143,146,810 subscription applications were received for 160,000 shares allocated to general investors in Genolution. Approximately 1.002 trillion KRW was gathered as subscription deposits.

Genolution previously recorded a competition rate of 1,161 to 1 with 1,206 participants in the demand forecast for institutional investors held from the 8th to the 9th.

Genolution plans to raise about 11.2 billion KRW through this public offering. Of the public offering funds, 10.7 billion KRW, excluding issuance costs, will be used for research and development, facility investment, and operating expenses.

A Genolution representative said, “We thank the general investors who recognized and showed interest in Genolution’s technology following institutional investors,” adding, “After listing, we will strive to enhance shareholder value by continuously advancing research and development to become a global leader in the gene sector.”

Meanwhile, Genolution’s market capitalization after listing is expected to be approximately 56.9 billion KRW based on the public offering price, and it is scheduled to be listed on the KOSDAQ market on the 24th.

This content was produced with the assistance of AI translation services.